Integration of consumer-focused tools and workforce development in harm reduction strategies for anabolic-androgenic steroids suggests needed evolution.
To remain evidence-based, harm reduction must evolve to be contextually relevant. We have used AAS as an example of this evolution, attempting to highlight cross-substance learnings which integrate consumer-focused tools, workforce development, and peer-led support.
No takes yet. Share an insight, caveat, or question.
Piatkowski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: